| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jan―09 |
Cover Feature: Structural Characterization and AI-Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS-CoV-2 Variants (Adv. Therap. 1/2026) |
Katja Hanack, Urszula Orzeł, Anja Schlör, Sourabh Mehta, Anandi Krishnan, Slawomir Filipek, et al. (+8) Rushika Patel, Madhvi Joshi, Markus Hoffmann, Stefan Pöhlmann, Chaitanya Joshi, Dorian Liepmann, Ramasamy Paulmurugan, Venkatesan Renugopalakrishnan |
| 2 |
[GO] |
2025―Oct―21 |
Structural Characterization and AI-Enhanced Modeling of a Broadly Neutralizing Camelid Antibody Against SARS-CoV-2 Variants |
Katja Hanack, Urszula Orzeł, Anja Schlör, Sourabh Mehta, Anandi Krishnan, Slawomir Filipek, et al. (+8) Rushika Patel, Madhvi Joshi, Markus Hoffmann, Stefan Pöhlmann, Chaitanya Joshi, Dorian Liepmann, Ramasamy Paulmurugan, Venkatesan Renugopalakrishnan |
| 3 |
[GO] |
2025―Jun―18 |
Mimicking Biochemical Traits with a Synthetic Lipid Nanoparticles SARS-COV-2 Model (Adv. Therap. 6/2025) |
Ignasia Handipta Mahardika, Hyun Park, Eunjin Huh, Changyoon Baek, Shin-Gyu Cho, Kwang-Hwan Jung, et al. (+2) Junhong Min, Kwanwoo Shin |
| 4 |
[GO] |
2025―Apr―28 |
Mimicking Biochemical Traits with a Synthetic Lipid Nanoparticles SARS-COV-2 Model |
Ignasia Handipta Mahardika, Hyun Park, Eunjin Huh, Changyoon Baek, Shin-Gyu Cho, Kwang-Hwan Jung, et al. (+2) Junhong Min, Kwanwoo Shin |
| 5 |
[GO] |
2022―Sep―12 |
Efficacy and Safety of Inosine Pranobex in COVID-19 Patients: A Multicenter Phase 3 Randomized Double-blind, Placebo-Controlled Trial |
C R Jayanthi, Ashok K Swain, Ranganath T Ganga, Dnyaneshwar Halnor, Ajit Avhad, Saif Khan, et al. (+7) Ayan Ghosh, Sumer Sanjiv Choudhary, Anand Namdevrao Yannawar, Shubhangi Despande, Manish Patel, Krishna Prasad Anne, Yogesh Bangar |
| 6 |
[GO] |
2021―Oct―21 |
Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach |
Vincent K. C. Yan, Xiaodong Li, Xuxiao Ye, Min Ou, Ruibang Luo, Qingpeng Zhang, et al. (+7) Bo Tang, Benjamin J. Cowling, Ivan Hung, Chung Wah Siu, Ian C. K. Wong, Reynold C. K. Cheng, Esther W. Chan |
| 7 |
[GO] |
2021―Aug―06 |
Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV |
Disha Panchal, Jeena Kataria, Kamiya Patel, Kaytlyn Crowe, Varun Pai, Abdul-Rahman Azizogli, et al. (+6) Neil Kadian, Sreya Sanyal, Abhishek Roy, Joseph Dodd-o, Amanda M. Acevedo-Jake, Vivek A. Kumar |
| 8 |
[GO] |
2021―Aug―02 |
Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants |
Jennifer M. Zupancic, John S. Schardt, Alec A. Desai, Emily K. Makowski, Matthew D. Smith, Ghasidit Pornnoppadol, et al. (+4) Mayara Garcia de Mattos Barbosa, Marilia Cascalho, Thomas M. Lanigan, Peter M. Tessier |
| 9 |
[GO] |
2021―Jul―20 |
Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity (Adv. Therap. 7/2021) |
Pratik Adhikary, Sashi Kandel, Umar-Farouk Mamani, Bahaa Mustafa, Siyuan Hao, Jianming Qiu, et al. (+7) John Fetse, Yanli Liu, Nurudeen Mohammed Ibrahim, Yongren Li, Chien-Yu Lin, Evanthia Omoscharka, Kun Cheng |
| 10 |
[GO] |
2021―Jun―11 |
Inhaled Dry Powder Formulation of Tamibarotene, a Broad-Spectrum Antiviral against Respiratory Viruses Including SARS-CoV-2 and Influenza Virus |
Qiuying Liao, Shuofeng Yuan, Jianli Cao, Kaiming Tang, Yingshan Qiu, Han Cong Seow, et al. (+7) Rico Chi-Hang Man, Zitong Shao, Yaoqiang Huang, Ronghui Liang, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Jenny Ka-Wing Lam |
| 11 |
[GO] |
2021―May―20 |
Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach |
Vincent K. C. Yan, Xiaodong Li, Xuxiao Ye, Min Ou, Ruibang Luo, Qingpeng Zhang, et al. (+7) Bo Tang, Benjamin J. Cowling, Ivan Hung, Chung Wah Siu, Ian C. K. Wong, Reynold C. K. Cheng, Esther W. Chan |
| 12 |
[GO] |
2021―May―17 |
Promising Immunotherapies against COVID-19 |
Haodong Guo, Lili Zhou, Zhenyu Ma, Zhixin Tian, Fangfang Zhou |
| 13 |
[GO] |
2021―Apr―26 |
Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity |
Pratik Adhikary, Sashi Kandel, Umar-Farouk Mamani, Bahaa Mustafa, Siyuan Hao, Jianming Qiu, et al. (+7) John Fetse, Yanli Liu, Nurudeen Mohammed Ibrahim, Yongren Li, Chien-Yu Lin, Evanthia Omoscharka, Kun Cheng |
| 14 |
[GO] |
2021―Feb―22 |
Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion |
Chan Yang, Xiaoyan Pan, Yuan Huang, Chen Cheng, Xinfeng Xu, Yan Wu, et al. (+9) Yunxia Xu, Weijuan Shang, Xiaoge Niu, Yihong Wan, Zhaofeng Li, Rong Zhang, Shuwen Liu, Gengfu Xiao, Wei Xu |
| 15 |
[GO] |
2021―Feb―14 |
Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2 |
Lauren Wells, Cory Vierra, Janee’ Hardman, Yanxiao Han, Dustin Dimas, Lucia N. Gwarada-Phillips, et al. (+5) Rachel Blackeye, Daryl K. Eggers, Celia C. LaBranche, Petr Král, Katherine D. McReynolds |
| 16 |
[GO] |
2020―Dec―16 |
Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies |
Zhina Hadisi, Tavia Walsh, Seyed Mohammad Hossein Dabiri, Amir Seyfoori, David Hamdi, Bahram Mirani, et al. (+3) Erik Pagan, Armando Jardim, Mohsen Akbari |
| 17 |
[GO] |
2020―Oct―26 |
Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector |
Taru Dube, Amrito Ghosh, Jibanananda Mishra, Uday B. Kompella, Jiban Jyoti Panda |
| 18 |
[GO] |
2020―Oct―14 |
Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus |
Joydeb Majumder, Tamara Minko |
|
